Gaggiano, Carla
Maselli, Anna
Sfikakis, Petros P.
Laskari, Katerina
Ragab, Gaafar
Hegazy, Mohamed Tharwat
Laymouna, Ahmed Hatem
Lopalco, Giuseppe
Almaghlouth, Ibrahim A.
Asfina, Kazi Nur
Alahmed, Ohoud
Giardini Mayrink, Henrique Ayres
Parente de Brito Antonelli, Isabele
Cattalini, Marco
Piga, Matteo
Sota, Jurgen
Gentileschi, Stefano
Maggio, Maria Cristina
Opris-Belinski, Daniela
Hatemi, Gülen
Insalaco, Antonella
Olivieri, Alma Nunzia
Tufan, Abdurrahman
Karadeniz, Hazan
Kardaş, Riza Can
La Torre, Francesco
Cardinale, Fabio
Marino, Achille
Guerriero, Silvana
Ruscitti, Piero
Tarsia, Maria
Vitale, Antonio
Caggiano, Valeria
Telesca, Salvatore
Iannone, Florenzo
Parretti, Veronica
Frassi, Micol
Aragona, Emma
Ciccia, Francesco
Wiesik-Szewczyk, Ewa
Ionescu, Ruxandra
Şahin, Ali
Akkoç, Nurullah
Hinojosa-Azaola, Andrea
Tharwat, Samar
Hernández-Rodríguez, José
Espinosa, Gerard
Conti, Giovanni
Del Giudice, Emanuela
Govoni, Marcello
Emmi, Giacomo
Fabiani, Claudia
Balistreri, Alberto
Frediani, Bruno
Rigante, Donato
Cantarini, Luca http://orcid.org/0000-0002-7352-1275
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Development and implementation of the AIDA International Registry for patients with Behçet’s disease
https://doi.org/10.1007/s11739-022-03038-1
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry
https://doi.org/10.1136/rmdopen-2023-003419
Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry
https://doi.org/10.1007/s40123-023-00863-1
Musculoskeletal manifestations in children with Behçet’s syndrome: data from the AIDA Network Behçet’s Syndrome Registry
https://doi.org/10.1007/s11739-023-03215-w
Funding for this research was provided by:
Università degli Studi di Siena
Article History
Received: 30 November 2022
Accepted: 30 January 2023
First Online: 7 March 2023
Declarations
:
: 15 of the authors of this publication are members of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA).
: The study was approved by the Ethics Committee of Azienda Ospedaliera Universitaria Senese, Siena, Italy (Ref. No.14951). Written informed consent for using clinical data for research purposes was obtained by the treating physician according to the local institutional review board guidelines.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: No animals were involved in the present study.